Both in Pharmaceuticals
Nomad Power Solutions vs Xilio Therapeutics
Over the past year NMAD returned +7.6% and XLO returned −15.2%; their daily moves had a correlation of 0.19.
NMAD +7.6% XLO −15.2%Growth of $1, one year, split-adjusted
| Metric | NMAD | XLO |
|---|---|---|
| Price | $3.81 | $7.57 |
| Market cap | $61.3M | $49.8M |
| Today | +5.83% | −5.73% |
| 1 month | +5.0% | −15.9% |
| 6 months | — | −8.9% |
| Year to date | — | −15.5% |
| 1 year | — | −28.2% |
| Revenue growth (YoY) | — | +131.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.8× |
| Net cash | — | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 26.3% |
| Short % of float | 10.5% | 10.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).